Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2003
05/22/2003US20030096813 Compositions useful as inhibitors of GSK-3
05/22/2003US20030096803 Such as 1-(6-(4-Fluoro-phenoxy)-pyridin-3-yl)-1,7,9-triaza-spiro(4.5)decane-2,6,8,10-tetraone for treatment of inflammation and cancer
05/22/2003US20030095958 Inhibiting beta amyloid converting enzyme responsible for A beta peptide cleavage to treat Alzheimer's Disease, Down's Syndrome, etc.
05/22/2003CA2467068A1 C-5 modified indazolylpyrrolotriazines
05/22/2003CA2466344A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
05/22/2003CA2465893A1 Polycyclic guanine derivative phosphodiesterase v inhibitors
05/21/2003EP1312367A1 Heterocyclo-alkylsulfonyl pyrazolesa and their use as COX-2 inhibitors
05/21/2003EP1312363A1 Methods of treatment and kits comprising a growth hormone secretagogue
05/21/2003EP1311511A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity
05/21/2003EP1311510A1 2,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones with an anticonvulsive action and methods for producing the same
05/21/2003EP1311263A2 Fused pyrrolocarbazoles against inflammation
05/21/2003EP1311252A2 Treatment of wounds
05/21/2003EP1186607B1 Optically active pyrrolopyridazine compounds
05/21/2003EP1129096B1 Crf receptor antagonists and methods relating thereto
05/21/2003CN1419557A Novel process for producing fused imidazopridine derivative and novel crystal form
05/21/2003CN1419553A Prodigiosin-derivatives as neoplastic and anti-viral agents
05/21/2003CN1418885A Process for preparing ferriporphyrin sodium salt
05/21/2003CN1418880A Process for preparing protoporphyrin disodium salt
05/21/2003CN1109023C Preparation of pyrimiding derivatives
05/20/2003US6566517 Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock
05/20/2003US6566367 Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines
05/20/2003US6566360 2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors
05/20/2003US6566357 Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
05/20/2003US6566355 Useful in combination with beta -lactam antibiotics in the control of beta -lactamase forming pathogens
05/20/2003US6566336 Compounds alkylating specific base sequence of DNA and method for synthesizing the same
05/20/2003CA2144962C 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers
05/20/2003CA2123606C New substituted pyrazolylpyrazoles, processes for their preparation, as well as intermediates, and their use as herbicides
05/15/2003WO2003040147A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease__________________________________________________________________________________________________________________________
05/15/2003WO2003040127A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
05/15/2003WO2003040125A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003WO2003040100A1 Compositions, methods and kits pertaining to luminescent compounds
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039539A2 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003WO2003039460A2 Mitotic kinesin inhibitors
05/15/2003WO2003039439A2 Deuterated pyrazolopyrimidinones and drugs containing said compounds
05/15/2003WO2003039259A1 Fungicides
05/15/2003WO2003000692A3 Oxytocin agonists
05/15/2003WO2002000629A9 Iminopyrimidine nmda nr2b receptor antagonists
05/15/2003US20030092908 Autoimmune diseases; rheumatic diseases; multiple sclerosis; inflammatory bowel disease; immunosuppressants
05/15/2003US20030092896 Rational syntheses of heteroleptic lanthanide sandwich coordination complexes
05/15/2003US20030092756 Antiproliferative agents
05/15/2003US20030092749 Kinase inhibitors; antiinflammatory agents; osteoporosis; anticancer agents
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003US20030092721 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092700 Benzazepine derivatives, medicaments containing the same and their use to prepare medicaments
05/15/2003US20030092676 Agents and method for the treatment of proliferative diseases
05/15/2003CA2470271A1 Deuterated pyrazolopyrimidinones and drugs containing said compounds
05/15/2003CA2466375A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465744A1 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003CA2465680A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003CA2465491A1 Mitotic kinesin inhibitors
05/15/2003CA2464685A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
05/14/2003EP1309721A2 Modulating multiple lineage kinase proteins
05/14/2003EP1309596A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/14/2003EP1309595A2 Synthesis of (r)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo(1,2-a) imidazol-2-one
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1140935B1 1,2-annelated quinoline derivatives
05/14/2003EP1107967B1 Triazolopyridazine derivatives for enhancing cognition
05/14/2003EP1019413B1 Metallation of macrocycles with 2,4-dicarbonyl-metal complexes
05/14/2003CN1418217A Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof
05/14/2003CN1418216A Novel 2,3,4,5-tetrahydro-1H-[1,4] diazepino [1,7a]indole compound
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1417210A Triazolpyrimidine compounds and their prepn and application
05/14/2003CN1108302C Process for resolving (R,S(Z))-alpha-(methoximino)-alpha-(1-azabicyclo (2,2,2) oct-3-yl) acetonitrile
05/13/2003US6563003 Process to produce amino alcohol salts
05/13/2003US6562981 Benzo (4,5) imidazo (2,1-a) isoindol-11-ones
05/13/2003US6562978 N-(3-(4-(4-(Aminocarbonyl)benzyl)-1-piperidinyl)propyl)-N-(3, 4-dichlorophenyl)-1-(methylsulfonyl)-4-piperidinecarboxamide or a salt thereof for treatment of AIDS
05/13/2003US6562971 Reaction of ethylenediamine in the presence of a zeolite catalyst, especially a zeolite MEL or MFI
05/13/2003US6562969 Ricin inhibitors and methods for use thereof
05/13/2003US6562819 Compounds for inhibition of ceramide-mediated signal transduction
05/13/2003US6562818 Irreversible inhibitors of tyrosine kinases
05/13/2003US6562816 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects
05/13/2003US6562813 Aralkyl and aralkylidene heterocyclic lactams and imides
05/13/2003US6562809 Contraction of coronary arteries may be mediated by its stimulation of the 5-HT1B (formerly 5-HT1D beta); compounds selective for a 5-HT1D receptor
05/13/2003US6562806 Pyrrolobenzodiazepines
05/13/2003CA2242097C Imidazotriazolopyrimidines, process for preparing them and their use as pharmaceutical compositions
05/13/2003CA2211681C Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
05/13/2003CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment
05/13/2003CA2021467C Heterocyclically substituted sulfonylureas, process for their preparation, and their use as herbicides or plant growth regulators
05/08/2003WO2003037902A1 Separation of regioisomers of metal phthalocyanines
05/08/2003WO2003037901A1 Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists
05/08/2003WO2003037900A2 Pyrazolopyrimidines
05/08/2003WO2003037899A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003WO2003037898A1 Pyrimido [4,5-b] indole derivatives
05/08/2003WO2003037897A2 Use of 7h-pyrrolo[2,3-d]pyrimidine derivatives in the treatment of solid tumor diseases
05/08/2003WO2003037896A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/08/2003WO2003037862A1 Amide derivatives and drugs
05/08/2003WO2003037432A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
05/08/2003WO2003037351A1 Heterocyclo-alkylsulfonyl pyrazoles and their use as cox-2 inhibitors
05/08/2003WO2003037338A2 Modulators of the cholesterol biosynthetic pathway
05/08/2003WO2003037086A1 Substituted thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)ones
05/08/2003WO2003004465A3 Fungicidal triazolopyrimidines, method for the production thereof and use thereof in controlling noxious fungi and agents containing said compounds
05/08/2003WO2002048152A3 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
05/08/2003WO2002039953A9 Texaphyrin coordination compounds and uses thereof
05/08/2003WO2002024226A9 Photosensitisers
1 ... 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 ... 573